Gengos Andrew
Insider CIK 1563623 · SYBX See Remarks · ATHA See Below · CYT Chief Business Officer · IMRX Chief Financial Officer · TERN Chief Financial Officer · TTRX Director · IMUC President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMRX Immuneering Corp | A Award deriv | 2026-07-16 | 2026-07-17 | 650,000 | — | $0 | 650,000 | SEC↗ |
| TTRX Turn Therapeutics Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 95,000 | — | $0 | 95,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 137,500 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer deriv | 2026-05-05 | 2026-05-05 | 750,000 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | D To issuer | 2026-05-05 | 2026-05-05 | 68,750 | $53.00 | $3.64M | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | U Tender | 2026-05-05 | 2026-05-05 | 40,503 | $53.00 | $2.15M | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2026-01-14 | 2026-01-16 | 137,500 | — | $0 | 137,500 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award | 2026-01-14 | 2026-01-16 | 68,750 | — | $0 | 101,788 | SEC↗ |
| TTRX Turn Therapeutics Inc. | A Award | 2025-10-08 | 2025-10-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2025-06-27 | 2025-06-30 | 5,000 | $3.93 | $19.6K | 20,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2025-06-27 | 2025-06-30 | 5,000 | $3.93 | $19.6K | 25,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2025-06-16 | 2025-06-16 | 5,000 | $3.95 | $19.8K | 15,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2025-06-13 | 2025-06-16 | 5,000 | $3.72 | $18.6K | 10,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2025-06-13 | 2025-06-16 | 5,000 | $3.75 | $18.8K | 5,000 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | A Award deriv | 2025-02-24 | 2025-02-25 | 750,000 | — | $0 | 750,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2024-09-05 | 2024-09-05 | 1,272 | $0.57 | $725 | 97,532 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-09-03 | 2024-09-05 | 5,000 | — | $0 | 98,804 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-05-20 | 2024-09-05 | 10,000 | $1.34 | $13.4K | 93,804 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 280,000 | — | $0 | 280,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2024-01-05 | 2024-02-16 | 1,208 | $2.91 | $3.5K | 83,804 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-01-04 | 2024-02-16 | 5,000 | — | $0 | 85,012 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-06-07 | 2023-06-09 | 2,859 | $3.40 | $9.7K | 68,293 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-06-07 | 2023-06-09 | 422 | $3.36 | $1.4K | 65,434 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-06-07 | 2023-06-09 | 11,719 | $3.44 | $40.3K | 80,012 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-06-05 | 2023-06-06 | 15,000 | $3.00 | $45.0K | 35,012 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-06-05 | 2023-06-06 | 10,000 | $3.00 | $30.0K | 55,012 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-06-05 | 2023-06-06 | 10,000 | $3.00 | $30.0K | 45,012 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-06-05 | 2023-06-06 | 10,000 | $3.02 | $30.2K | 65,012 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-06-02 | 2023-06-06 | 3,418 | $2.95 | $10.1K | 20,012 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-06-02 | 2023-06-06 | 6,582 | $2.86 | $18.8K | 16,594 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2023-06-02 | 2023-06-06 | 10,012 | $2.75 | $27.5K | 10,012 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2023-05-18 | 2023-05-22 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2023-01-05 | 2024-01-08 | 1,208 | $2.91 | $3.5K | 83,804 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2023-01-04 | 2024-01-08 | 5,000 | — | $0 | 85,012 | SEC↗ |
| CYT Cyteir Therapeutics, Inc. | A Award deriv | 2022-02-22 | 2022-02-24 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2018-03-14 | 2018-03-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award deriv | 2017-10-31 | 2017-12-22 | 154,000 | — | $0 | 154,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | F Tax w/h | 2016-12-31 | 2017-02-13 | 3,284 | $2.05 | $6.7K | 5,249 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2016-03-11 | 2016-03-15 | 350,000 | — | $0 | 350,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award | 2016-03-11 | 2016-03-15 | 150,000 | — | $0 | 341,333 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | P Buy | 2015-11-30 | 2015-12-02 | 10,000 | $0.44 | $4.4K | 47,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2015-03-20 | 2015-03-24 | 175,000 | — | $0 | 175,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2015-03-20 | 2015-03-24 | 175,000 | — | $0 | 175,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award | 2015-03-20 | 2015-03-24 | 150,000 | — | $0 | 228,333 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | P Buy deriv | 2015-02-18 | 2015-02-20 | 28,933 | — | $0 | 28,933 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | P Buy | 2015-02-18 | 2015-02-20 | 41,333 | $0.60 | $24.8K | 78,333 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | P Buy | 2014-08-14 | 2014-08-14 | 10,000 | $0.90 | $9.0K | 37,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2014-03-07 | 2014-03-10 | 200,000 | — | $0 | 200,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | P Buy | 2013-12-18 | 2013-12-18 | 27,000 | $0.72 | $19.4K | 27,000 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2012-12-03 | 2012-12-05 | 700,000 | — | $0 | 700,000 | SEC↗ |